Abstract
Computational de novo protein design tailors proteins for target structures and oligomerisation states with high stability, which allows overcoming many limitations of natural proteins when redesigned for new functions. Despite significant advances in the field over the past decade, it remains challenging to predict sequences that will fold as stable monomers in solution or binders to a particular protein target; thereby requiring substantial experimental resources to identify proteins with the desired properties. To overcome this, here we leveraged the large amount of design data accumulated in the last decade, and the breakthrough in protein structure prediction from last year to investigate on improved ways of selecting promising designs before experimental testing. We collected de novo proteins from previous studies, 518 designed as monomers of different folds and 2112 as binders against the Botulinum neurotoxin, and analysed their structures with AlphaFold2, RoseTTAFold and fragment quality descriptors in combination with other properties related to surface interactions. These features showed high complementarity in rationalizing the experimental results, which allowed us to generate quite accurate machine learning models for predicting well-folded monomers and binders with a small set of descriptors. Cross-validating designs with varied orthogonal computational techniques should guide us for identifying design imperfections, rescuing designs and making more robust design selections before experimental testing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.